Unblocking or activation of the cellular immune mechanism by induced proteolysis in patients with cancer.
D000230:Adenocarcinoma / Q000276:immunology; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D003110:Colonic Neoplasms / Q000276:immunology; D005260:Female; D005910:Glioma / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects*; D007167:Immunotherapy; D007275:Injections, Intravenous; D008213:Lymphocyte Activation / Q000187:drug effects; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology; D008297:Male; D008545:Melanoma / Q000276:immunology; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D010051:Ovarian Neoplasms / Q000276:immunology; D010447:Peptide Hydrolases / Q000008:administration & dosage / Q000494:pharmacology*; D012882:Skin Tests; D013300:Streptokinase / Q000008:administration & dosage / Q000494:pharmacology
D010447:Peptide Hydrolases; D013300:Streptokinase